01—Abstract
Summary
Summary of the 8-K filed June 5, 2024. Cited figures are marked; the original filing is the authoritative source.
On June 5, 2024, Alphabet Inc. announced the appointment of Anat Ashkenazi as its new Chief Financial Officer and Senior Vice President, effective July 31, 2024, as disclosed in an Item 5.02 filing.
Ashkenazi, age 51, currently serves as Executive Vice President and CFO of Eli Lilly and Company, a role she has held after more than 23 years at that company, where she joined in 2001 and held progressively senior financial, strategy, and operations positions, including CFO roles for several global divisions. She will report to CEO Sundar Pichai and be based in the Bay Area. The filing is primarily a leadership transition rather than a financial disclosure: it contains no earnings, guidance, or financial statement data.
The change follows Ruth Porat's July 2023 move to President & Chief Investment Officer. Porat remains CFO until Ashkenazi starts, including through Alphabet's Q2 2024 earnings, which provides a continuous finance leadership handoff. For investors, the appointment signals management's emphasis on disciplined, long-term investment to support AI-driven growth, as framed by Pichai.
The filing does not disclose compensation terms, which Alphabet has said it will separately provide under Item 5.02(c)(3). Investors should watch for those details, as well as any changes in capital allocation priorities under the new CFO.
02—Key points
Key Highlights
- Anat Ashkenazi named Chief Financial Officer and Senior Vice President of Alphabet and Google, effective July 31, 2024
- Ashkenazi brings 23+ years of Eli Lilly experience, including EVP and CFO at Eli Lilly and CFO roles across multiple global divisions
- Ruth Porat remains CFO through the Q2 2024 earnings release to ensure a smooth transition
- Ashkenazi will report directly to CEO Sundar Pichai and be based in the Bay Area
- Management emphasizes long-term investment in AI to drive innovation and growth across core products and new offerings
- Compensation arrangements not disclosed in this filing; Alphabet will provide them separately per Item 5.02(c)(3)
- No financial results, guidance, or financial statements included in this 8-K
03—Questions
Frequently Asked Questions
Who is replacing Ruth Porat as CFO and when does the change take effect?
Anat Ashkenazi, currently EVP and CFO of Eli Lilly, will become Alphabet's CFO and SVP effective July 31, 2024. Ruth Porat, who moved to President & Chief Investment Officer in July 2023, stays as CFO until Ashkenazi starts, including through the Q2 2024 earnings.
What is Ashkenazi's background?
She joined Eli Lilly in 2001 and spent over 23 years there in financial, strategy, and operations roles. She served as SVP, Controller and CFO of Lilly Research Laboratories, and as CFO for several global divisions including Oncology, Diabetes, Global Manufacturing & Quality, and Research & Development. She holds an MBA from Tel Aviv University and a BA in economics and business administration from the Hebrew University.
Does this announcement affect Alphabet's financial outlook?
The filing contains no financial results, guidance, or forward-looking financial metrics. It is a management change only, so no direct impact on reported financials is disclosed.
What did Alphabet say about the new CFO's priorities?
Sundar Pichai said he values Ashkenazi's track record of strategic focus on long-term investment to fuel innovation and growth, and that he expects her to help invest responsibly to support the company's next wave of growth in the AI era.
When will Alphabet disclose Ashkenazi's compensation?
The 8-K states that Alphabet will separately provide the information required by Item 5.02(c)(3) of Form 8-K, which covers compensatory arrangements for the new officer. The details were not included in this filing.
04—Continue